ACADIA Pharmaceuticals
ACAD
£15.35
Share price
-1.37%
Change (1 day)
25.59%
Change (1 year)
Categories
ACADIA Pharmaceuticals (ACAD) - Total debt
Total debt on the balance sheet as of March 2025 : £41.03 Million
According to ACADIA Pharmaceuticals's latest financial reports the company's total debt is £41.03 Million. A company’s total debt is the sum of all current and non-current debts.
ACADIA Pharmaceuticals - Total debt on balance sheet (from 2003 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | £41.43 M | -7.72% |
| 2023-12-31 | £44.9 M | -12.38% |
| 2022-12-31 | £51.24 M | 7.37% |
| 2021-12-31 | £47.73 M | 31.31% |
| 2020-12-31 | £36.34 M | 386.63% |
| 2019-12-31 | £7.46 M | |
| 2018-12-31 | N/A | |
| 2011-12-31 | £0.02 M | -71.11% |
| 2010-12-31 | £0.07 M | -75.1% |
| 2009-12-31 | £0.28 M | -65.77% |
| 2008-12-31 | £0.83 M | -22.19% |
| 2007-12-31 | £1.07 M | -11.41% |
| 2006-12-31 | £1.21 M | 17.34% |
| 2005-12-31 | £1.03 M | -21.59% |
| 2004-12-31 | £1.31 M | -51.56% |
| 2003-12-31 | £2.72 M | -32.2% |
| 2002-12-31 | £4.01 M | 339.76% |
| 2001-12-31 | £0.91 M | -76.47% |
| 2000-12-31 | £3.87 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Vanda Pharmaceuticals VNDA | £8.6 M | -79.03% | 🇺🇸 USA |
 Pfizer PFE | £44.90 B | 109,336.49% | 🇺🇸 USA |
 Eli Lilly LLY | £28.21 B | 68,671.02% | 🇺🇸 USA |
 Johnson & Johnson JNJ | £38.28 B | 93,197.15% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | £37.54 B | 91,388.41% | 🇺🇸 USA |
 Adamas Pharmaceuticals
ADMS | N/A | N/A | 🇺🇸 USA |